125 results on '"Skoff, Tami H"'
Search Results
2. Assessing the Impact of the 2020 Council of State and Territorial Epidemiologists Case Definition for Pertussis on Reported Pertussis Cases
3. Differences in Pertussis Incidence by Race and Ethnicity in the United States, 2010–2017
4. Evaluation of Asymptomatic Bordetella Carriage in a Convenience Sample of Children and Adolescents in Atlanta, Georgia, United States
5. Vital Signs : Burden and Prevention of Influenza and Pertussis Among Pregnant Women and Infants — United States
6. Twenty Years of Active Bacterial Core Surveillance - Volume 21, Number 9—September 2015 - Emerging Infectious Diseases journal - CDC
7. Influenza, Tdap, and COVID-19 Vaccination Coverage and Hesitancy Among Pregnant Women — United States, April 2023
8. Impact of the US Maternal Tetanus, Diphtheria, and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants : A Case-Control Evaluation
9. Surveillance of Vaccination Coverage Among Adult Populations — United States, 2015
10. An Assessment of the Cocooning Strategy for Preventing Infant Pertussis—United States, 2011
11. Evaluation of Asymptomatic Bordetella Carriage in a Convenience Sample of Children and Adolescents in Atlanta, Georgia, United States.
12. Public health consequences
13. US Infant Pertussis Incidence Trends Before and After Implementation of the Maternal Tetanus, Diphtheria, and Pertussis Vaccine
14. Surveillance of Vaccination Coverage Among Adult Populations — United States, 2014
15. Evaluation of Asymptomatic BordetellaCarriage in a Convenience Sample of Children and Adolescents in Atlanta, Georgia, United States
16. Pertactin-Negative Bordetella pertussis Strains: Evidence for a Possible Selective Advantage
17. High post-exposure prophylaxis (PEP) uptake among household contacts of pertussis patients enrolled in a PEP effectiveness evaluation – United States, 2015–2017.
18. Changes in predominance of pulsed-field gel electrophoresis profiles of Bordetella pertussis Isolates, United States, 2000-2012
19. Bordetella pertussis strain lacking pertactin and pertussis toxin
20. Maternal Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccination During Pregnancy: Impact on Infant Anti-Pertussis Antibody Concentrations by Maternal Pertussis Priming Series
21. Effect of culture-independent diagnostic tests on future emerging infections program surveillance
22. Tracking pertussis and evaluating control measures through enhanced pertussis surveillance, emerging infections program, United States
23. Maternal Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccination During Pregnancy: Impact on Infant Anti-Pertussis Antibody Concentrations by Maternal Pertussis Priming Series.
24. US Infant Pertussis Incidence Trends Before and After Implementation of the Maternal Tetanus, Diphtheria, and Pertussis Vaccine.
25. Increasing Burden of Invasive Group B Streptococcal Disease in Nonpregnant Adults, 1990–2007
26. Population diversity among Bordetella pertussis isolates, United States, 1935-2009
27. Early Impact of the US Tdap Vaccination Program on Pertussis Trends
28. Pertussis Infections Among Pregnant Women in the United States, 2012–2017
29. Cluster of deaths from group A streptococcus in a long-term care facility—Georgia, 2001
30. Pertussis Infections Among Pregnant Women in the United States, 2012–2017.
31. Maternal Vaccination in Argentina: Tetanus, Diphtheria, and Acellular Pertussis Vaccine Effectiveness During Pregnancy in Preventing Pertussis in Infants <2 Months of Age
32. The Impact of the U.S. Maternal Tdap Vaccination Program on Preventing Pertussis in Infants <2 Months of Age: A Case-control Evaluation
33. Maternal Vaccination in Argentina: Tetanus, Diphtheria, and Acellular Pertussis Vaccine Effectiveness During Pregnancy in Preventing Pertussis in Infants <2 Months of Age.
34. Severe Pertussis Infections in the United States, 2011–2015
35. The Epidemiology of Nationally Reported Pertussis in the United States, 2000–2016
36. Impact of the US Maternal Tetanus, Diphtheria, and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants <2 Months of Age: A Case-Control Evaluation
37. Severe Pertussis Infections in the United States, 2011–2015.
38. The Epidemiology of Nationally Reported Pertussis in the United States, 2000–2016.
39. Impact of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccinations on Reported Pertussis Cases Among Those 11 to 18 Years of Age in an Era of Waning Pertussis Immunity
40. Changes in Predominance of Pulsed-Field Gel Electrophoresis Profiles ofBordetella pertussisIsolates, United States, 2000–2012
41. Trends in Pertussis Diagnostic Testing in the United States, 1990 to 2012
42. Twenty Years of Active Bacterial Core Surveillance.
43. Sources of Infant Pertussis Infection in the United States
44. Waning Immunity to Pertussis Following 5 Doses of DTaP
45. Population Diversity amongBordetella pertussisIsolates, United States, 1935–2009
46. Active, Population‐Based Surveillance for Infectious Diseases
47. Pertussis rates dropping post-vaccine use.
48. Tetanus, Diphtheria, and Acellular Pertussis Vaccination Coverage among Publicly Insured Pregnant Women, United States, 2016-2019
49. Pertussis and influenza immunization: perceived attitude and decision of postpartum patients.
50. Evaluating the Effect of Standard of Care Treatment on Burden of Chronic Hepatitis B: A Retrospective Analysis of the United States Veterans Population.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.